UCLA Presents voteview.com beta 3
Welcome! We have just updated Voteview's aging codebase. In the process, we have fixed some nagging issues, added a few new features, and
improved performance. If you notice anything that used to work that no longer does, please let us know.
116th Congress > House > Vote 186
Clerk session vote number: 187
Sponsor: KELLY, Robin L. (D-IL)
Description: Orange Book Transparency Act
Bill summary:
Orange Book Transparency Act of 2020
This bill modifies requirements for the Food and Drug Administration (FDA) to list and publish drug patent and exclusivity information. Specifically, the FDA must include on its list certain patent information and must specify each drug exclusivity period that has not concluded.The holder of an approved drug application must notify the FDA when a listed patent is invalidated by a court or by the Patent Trial and Appeal Board. The FDA must remove invalidated patents from its list, subject to the 180-day drug exclusivity period.
Bill titles: To amend the Federal Food, Drug, and Cosmetic Act regarding the list under section 505(j)(7) of the Federal Food, Drug, and Cosmetic Act, and for other purposes.
Links for more info on the vote: congress.gov
Loading graphics...
Error!
Member Vote Map
Vote Ideological Breakdown
This chart describes how members voted on the rollcall. Members are placed according to their NOMINATE ideological scores.
A cutting line divides the vote into those expected to vote "Yea" and those expected to vote "Nay". The shaded heatmap reflects
the expected probability of voting "Yea". You can select points or regions to subset the members listed above and below.
Votes
Selected:
of
from
including
with NOMINATE scores within .